Rarebase

Curated by Signal

Provider of AI-based drug discovery platform for rare diseases

Overview

Provider of AI-based drug discovery platform for rare diseases. It offers FUNCTION product engine which combines science and high-throughput technology to discover disease-modifying therapies. It allows to screen small molecule compounds and map their effect on gene expression at near genome scale.

Key facts

Founded: 2020
Headquarters: Palo Alto, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Doctorite
Behavioral health care management platform
Health TechnologyDallas, United States
Alo Moves
Online platform offering fitness and yoga sessions
Health TechnologyBeverly Hills, United States
Ketodoc
Provider of a ketone and glucose blood meter kit
Health TechnologyLos Angeles, United States

About Rarebase

What does Rarebase do?

Provider of AI-based drug discovery platform for rare diseases.

Where is Rarebase headquartered?

Rarebase is headquartered in Palo Alto, United States.

When was Rarebase founded?

Rarebase was founded in 2020.

Which sector is Rarebase in?

Rarebase operates in Health Technology.

Who are Rarebase's competitors?

Companies similar to Rarebase include Doctorite, Alo Moves, and Ketodoc.